MRPL52 and breast cancer: Here, we first identified MRPL52 as a hypoxia-regulated protein in a HIF-1-dependent manner; its upregulation was significantly correlated with higher metastatic risk and poorer clinicopathological characteristics in a set of human BC specimens.